Most newsletters covering this market are written by people who have never had to make the decision.
We have. The Clinic Brief is written by two operators who run cash-pay clinics and a telehealth platform — which means every regulatory item we cover, we have already had to answer for ourselves, usually badly, before we wrote it up.
That is the whole editorial premise. We are not neutral observers of this industry. We are in it. The value of this brief is not detachment — it's that we are making the same decisions you are, roughly one quarter ahead of when you'll need to, and we attach the primary source every time so you never have to take our word for it.
Devin Casey, MBA — the business side. He's the operations half of BioPeakRx, a Navy veteran, and the one responsible for pharmacy sourcing, compliance infrastructure, payment rails and the technology underneath it all. In practice that means the unglamorous plumbing that quietly decides whether a clinic is profitable — the stuff nobody puts on a website and everybody finds out about the hard way. He built AEGIS, the regulatory-monitoring system behind the Radar, for the ordinary reason that nobody was selling one and the alternative was hearing about a rule change from a patient. He also writes the MBA Playbook series — The MBA Playbook for Small Business and The MBA Playbook for Hiring & Managing Your First Team, with a third on small clinics in draft — and through Elaren Advisors he does this work for operators outside his own clinics too.
Ryan Arvizo, FNP-C — the clinical side. An Arizona native, a first-generation college graduate, and a board-certified family nurse practitioner with 14+ years in healthcare. He is the clinical owner of BioPeakRx and holds full authority over every prescription written on the platform — which, if you operate in a corporate-practice-of-medicine state, is a structure you already recognize and probably lose sleep over. He's licensed in nine states: Arizona, California, Colorado, Florida, Nevada, New Mexico, Texas, Utah and Washington. That matters more than a credential line usually does. The state-by-state patchwork this brief keeps writing about — where a peptide is dispensable, what a supervising relationship requires, which board has an opinion about telehealth this quarter — isn't abstract to him. He practices inside nine versions of it at once, and he's the clinical voice on everything we publish about prescribing, documentation and scope.
Where to find us. Devin posts the Operator Lesson and whatever’s moving on the regulatory side on LinkedIn — that’s the place to argue with us in public. Ryan isn’t on LinkedIn. Honestly, the best channel for either of us is the reply button on any issue: it comes straight to us, and we read everything.
We'll say this plainly, because you should be able to weigh it:
Some of what we write about, we sell. Here is how we keep that from bending the coverage.
1. The Radar never carries a pitch. No promotion for anything we own appears in, above or below the Radar or the Watchlist. Those sections are the product. If we ever put an offer next to a regulatory item, you should stop trusting the regulatory items — so we don't.
2. The primary source is always attached. Every claim links to the government document it came from — the warning letter, the Federal Register notice, the FDA guidance page. Not a law firm's summary of it, not a trade article about it. If we can't link the source, we don't run the item.
3. Disclosure goes in the same sentence, not the fine print. When we mention something we have a stake in, we say so where you're reading, not at the bottom.
4. We don't take money per referral. Nothing in this brief, and no arrangement behind it, is paid on patient volume. Where we have commercial relationships in healthcare, they are flat-fee. That's a legal line in this industry and it's also the only structure that lets us write honestly about vendors.
5. We correct in public. When we get something wrong, the correction runs in the next issue with the same prominence as the original. We'd rather be the newsletter that visibly fixes things than the one that quietly edits them.
A weekly brief, Thursday mornings, in three parts:
No legal advice, no medical advice, no vendor press releases.
The Clinic Brief is business and regulatory information, not legal or medical advice. Talk to qualified healthcare counsel about your specific situation.